1st Circ. Suggests Appeal In Drug Rebate Case May Be Moot
A First Circuit panel raised mootness concerns as it heard arguments Tuesday from drug companies appealing a ruling that prevented them from intervening in a now-dismissed case to defend a rebate...To view the full article, register now.
Already a subscriber? Click here to view full article